HRP990341B1 - Process for the preparation of mometasone furoate - Google Patents

Process for the preparation of mometasone furoate

Info

Publication number
HRP990341B1
HRP990341B1 HR990341A HRP990341A HRP990341B1 HR P990341 B1 HRP990341 B1 HR P990341B1 HR 990341 A HR990341 A HR 990341A HR P990341 A HRP990341 A HR P990341A HR P990341 B1 HRP990341 B1 HR P990341B1
Authority
HR
Croatia
Prior art keywords
preparation
mometasone furoate
mometasone
furoate
free
Prior art date
Application number
HR990341A
Other languages
English (en)
Inventor
William Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of HRP990341A2 publication Critical patent/HRP990341A2/hr
Publication of HRP990341B1 publication Critical patent/HRP990341B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR990341A 1999-08-02 1999-11-05 Process for the preparation of mometasone furoate HRP990341B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (2)

Publication Number Publication Date
HRP990341A2 HRP990341A2 (en) 2001-04-30
HRP990341B1 true HRP990341B1 (en) 2003-10-31

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
HR990341A HRP990341B1 (en) 1999-08-02 1999-11-05 Process for the preparation of mometasone furoate

Country Status (22)

Country Link
US (1) US6177560B1 (fr)
EP (1) EP1074558B1 (fr)
JP (1) JP3746174B2 (fr)
KR (1) KR100640066B1 (fr)
CN (1) CN1149222C (fr)
AT (1) ATE229970T1 (fr)
AU (1) AU765592B2 (fr)
CA (1) CA2295455C (fr)
DE (1) DE69904585T2 (fr)
DK (1) DK1074558T3 (fr)
ES (1) ES2189354T3 (fr)
HR (1) HRP990341B1 (fr)
HU (1) HU227494B1 (fr)
IL (1) IL133752A (fr)
NO (1) NO321154B1 (fr)
NZ (1) NZ500555A (fr)
PL (1) PL191103B1 (fr)
PT (1) PT102343B (fr)
RU (1) RU2208616C2 (fr)
SI (1) SI1074558T1 (fr)
UA (1) UA60333C2 (fr)
ZA (1) ZA996758B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (fr) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Système de revêtement contenant un phase pyrochlor mixte de Gadolinium.
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
EP2999460A1 (fr) 2013-05-22 2016-03-30 Pearl Therapeutics, Inc. Compositions, procedes& systemes pour l'administration par voie respiratoire d'au moins trois agents actifs
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CA3226557A1 (fr) 2021-07-09 2023-01-12 Astrazeneca Pharmaceuticals Lp Compositions, procedes et systemes pour l'administration d'un medicament en aerosol
WO2023119093A1 (fr) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, procédés et systèmes d'administration d'un médicament en aérosol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
CN1158296C (zh) * 1996-06-28 2004-07-21 先灵公司 9α,21-二卤代-孕甾烷-11β,17α-二醇-20-酮的17-酯的制备方法
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
KR20010020094A (ko) 2001-03-15
IL133752A0 (en) 2001-04-30
HU9903747D0 (en) 1999-12-28
DK1074558T3 (da) 2003-04-07
PL336452A1 (en) 2001-02-12
EP1074558A1 (fr) 2001-02-07
UA60333C2 (uk) 2003-10-15
NO995225L (no) 2001-02-05
CN1282744A (zh) 2001-02-07
IL133752A (en) 2004-02-19
AU765592B2 (en) 2003-09-25
CN1149222C (zh) 2004-05-12
DE69904585T2 (de) 2003-05-15
ES2189354T3 (es) 2003-07-01
HUP9903747A2 (hu) 2001-05-28
PT102343A (pt) 2001-02-28
NO321154B1 (no) 2006-03-27
HRP990341A2 (en) 2001-04-30
NO995225D0 (no) 1999-10-26
JP3746174B2 (ja) 2006-02-15
PL191103B1 (pl) 2006-03-31
EP1074558B1 (fr) 2002-12-18
HUP9903747A3 (en) 2001-07-30
CA2295455C (fr) 2008-03-25
PT102343B (pt) 2003-11-28
DE69904585D1 (de) 2003-01-30
ATE229970T1 (de) 2003-01-15
ZA996758B (en) 2000-08-30
HU227494B1 (en) 2011-07-28
US6177560B1 (en) 2001-01-23
KR100640066B1 (ko) 2006-10-31
RU2208616C2 (ru) 2003-07-20
SI1074558T1 (en) 2003-04-30
JP2001048897A (ja) 2001-02-20
CA2295455A1 (fr) 2001-02-02
NZ500555A (en) 2000-11-24
AU5602499A (en) 2001-02-08

Similar Documents

Publication Publication Date Title
IL126339A (en) Taxol derivatives
HRP990341B1 (en) Process for the preparation of mometasone furoate
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
EP1401433A4 (fr) Analogues a conformation contrainte utilises en tant qu'agents contre le diabete et contre l'obesite, et procede associe
WO2002032898A3 (fr) Nouveaux anticholinergiques, leurs procedes de production et leur utilisation en tant que medicaments
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
DK0717041T3 (da) Krystallinske paclitaxel-hydrater
WO2001045678A3 (fr) Medicament, son procede de production et son utilisation
ZA200201816B (en) A vaccine composition and method of using the same.
AP9400621A0 (en) Influenza vaccine compositions
AU1951495A (en) Alphavirus rna as carrier for vaccines
HK1026146A1 (en) A universally applicable blood plasma
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
BG103289A (en) Method for yohexene preparation
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
FI945414A (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
AU3514699A (en) A method for inputting chinese characters by codes of constructed parts of the chinese character
SI0934780T1 (fr)
FR2686090B1 (fr) Composition a base de polysilane(s), non degradable par hydrosilylation.
HU9801086D0 (en) New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component
IT1294969B1 (it) Composizione immunogena per hiv

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20181005

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20191105